American Marconi Wireless News - Paragon Technologies Provides Update on CEO Succession Plan

NYSE - LSE

CMSC	0.4%	22.314	$
CMSD	0.11%	22.285	$
RBGPF	0%	69.04	$
SCS	0.37%	10.74	$
RELX	0.06%	53	$
RIO	-0.24%	59.33	$
GSK	0.31%	41.45	$
NGG	0.38%	71.48	$
BP	0.58%	30.4	$
BTI	1.48%	48.215	$
BCC	0.87%	91.02	$
JRI	0.15%	13.13	$
VOD	0.1%	9.85	$
BCE	-0.27%	22.445	$
RYCEF	0.83%	12	$
AZN	-0.16%	73.71	$

Paragon Technologies Provides Update on CEO Succession Plan

TECHNOLOGY 12.06.2025

EASTON, PA / ACCESS Newswire / June 12, 2025 / Paragon Technologies, Inc. (OTC PINK:PGNT), a diversified holding company, today provided an update on its CEO succession plan. As previously disclosed, Interim CEO, Sam Weiser will not seek re-election at the upcoming Annual Meeting of Stockholders on June 30, 2025, and will cease his role as Interim CEO on that date.

Text size:

If Paragon's director slate prevails over Hesham "Sham" Gad's slate in the proxy contest at the Annual Meeting, the newly constituted board will meet and it is expected that one of the board members on Paragon's slate will serve as Interim CEO after the Annual Meeting. The Board will promptly commence a CEO search to identify the next CEO with the goal of having a permanent CEO in place by October 1, 2025. We have already had some very qualified executives reach out and express interest. The Company is committed to conducting a thorough and comprehensive search process to identify an exceptional leader who will drive Paragon Technologies' continued innovation and growth.

About Paragon Technologies

Paragon Technologies, Inc. is a holding company owning subsidiaries that engage in diverse business activities, including material handling, distribution, real estate, and investments. For additional information please visit: www.pgntgroup.com.

Investor Relations Contact:

Alliance Advisors IR
[email protected]

SOURCE: Paragon Technologies Inc.

View the original press release on ACCESS Newswire

L.Harper--AMWN

Featured

GA-ASI Adds Saab Airborne Early Warning Capability to MQ-9B

GA-ASI Announces New PELE Small UAS for International Customers

Big tech on a quest for ideal AI device

Adolore BioTherapeutics Announces Publication Demonstrating Biosafety and Efficacy of Kv7 Activating rdHSV-CA8* Analgesic Gene Therapy for Chronic Pain via the Intra-Articular Route in Mice